SUMMIT PROGRAMME · UK MEDICAL CANNABIS INVESTMENT SUMMIT · 2027

Summit Agenda 2027

The full programme for the UK Medical Cannabis Investment Summit 2027 — keynotes, panel discussions, investor roundtables and networking sessions. Updated on a rolling basis as sessions are confirmed.

Confirmed Programme Themes

The detailed session-by-session agenda will be published when speaker confirmations are complete. The following themes are confirmed for the 2027 programme.

KEYNOTE

The UK Medical Cannabis Market in 2027 — State of the Sector

An opening keynote providing the definitive data-led overview of the UK medical cannabis market — patient numbers, prescription volumes, clinic landscape, supply chain maturity and the investment opportunity as it stands in 2027.

PANEL DISCUSSION

Institutional Capital Enters the Room — Family Offices and VC in UK Cannabis

How institutional investors are evaluating the UK medical cannabis sector, what they need to see before committing capital and where the most credible opportunities sit across the value chain.

PANEL DISCUSSION

The Clinical Frontier — Conditions, Prescribing and the Path to NHS Commissioning

Where prescribing is growing fastest, which conditions are driving patient demand, what the evidence base looks like and what NHS commissioning would mean for the investment landscape.

INVESTOR ROUNDTABLE

Deal Flow Intelligence — Active Transactions, Valuations and M&A in UK Cannabis

A closed, Chatham House Rule roundtable for verified investors sharing active deal flow intelligence, valuation benchmarks and M&A activity across the UK cannabis sector.

PANEL DISCUSSION

Regulatory Trajectory — MHRA, Home Office and the Policy Horizon to 2030

What the regulatory environment looks like for the next three years, what changes would unlock the most significant investment opportunity and how operators should be positioning for the regulatory trajectory.

KEYNOTE

Global Context — Germany, Europe and What UK Investors Can Learn

Germany's medical cannabis market reached an estimated €670 million in 2025 — the largest in Europe. What the German experience tells UK investors about the trajectory of a maturing medical cannabis market.

PANEL DISCUSSION

Building for Exit — What Acquirers Want in a UK Cannabis Business

What strategic acquirers — pharma, life sciences, healthcare services and consumer wellness companies — are looking for in UK cannabis assets, and how founders should be structuring their businesses for institutional and strategic exit.

NETWORKING

Investor Roundtables and Structured Networking

Structured one-to-one and small group networking sessions matching investors with operators, founders with advisers and policymakers with capital. Format and matching process confirmed closer to the event.

Full Agenda — Coming Soon

The session-by-session agenda with confirmed speakers, timings and room allocations will be published here as soon as speaker confirmations are complete. Register now to be notified directly when the full agenda is released.

Register for Agenda Updates →